1. Introduction {#s0005}
===============

Stroke refers to acute or chronic cerebrovascular diseases caused by various causes. It is one of the most common diseases which may cause death or permanent disability in the world. In China, stroke is the first cause of disability and death ([@b0025], [@b0075], [@b0095]). In recent years, the incidence of stroke has been increased at younger age ([@b0015]). Previous studies have demonstrated that the incidence rate of stroke among young population is approximately 97.7/100 000 in China, which is significantly higher than that in Western countries ([@b0030]). 85% of strokes were confirmed to be ischemic stroke (IS) ([@b0080]). It is important to properly implement the prevention, diagnosis and treatment of ischemic stroke in young adults ([@b0005], [@b0035]). It has been confirmed that IS was a result of multiple factors, such as chronic diseases, inflammation, and genetic variants ([@b0010]). Genetic factors play a key predisposing role of IS in family and twin studies ([@b0060]).

The phosphodiesterase 4D (PDE4D) gene plays an important role in the degradation of cyclic adenosine monophosphate (cAMP). It is the only stroke-related gene acquired by the Genome-wide association study (GWAS) in recent years, which has been proven to be associated with the incidence of familial IS. There are six SNPs (SNP41, SNP45, SNP56, SNP83, SNP87 and SNP89) were reported to be associated with the risk of stroke. The SNP83 and SNP87 polymorphism have a focus for researches. However, the results are conflicting ([@b0045], [@b0090], [@b0085]). We could not eliminate the feasibility that gene detection technology, sample size, genetic background and other factors contributed to these contradictory results.

In this study, high-throughput gene sequencing technology was adopted to analyze the association between the SNP83, SNP87 polymorphism and IS in young adults, aiming to investigate the genetic pathogenesis of stroke at the molecular level to prevent and provide theoretical basis for the prevention and treatment of stroke in young population.

2. Materials and methods {#s0010}
========================

2.1. Study population {#s0015}
---------------------

From June 2014 to January 2017, 193 young stroke patients admitted to the neurology department of the First Affiliated Hospital of Xinxiang Medical College were recruited in this study. Inclusion criteria (1) Those with initial episode of stroke. (2) Aged 18--45 years. (3) Sampling collection and necessary examinations were completed with 1 week after the onset of stroke. (4) Ischemic stroke was diagnosed according to the International Classification of Diseases, 10th revision (ICD10). Another matched 200 healthy subjects, aged 18--45 years, receiving physical examination in our hospital were assigned into the control group. All enrolled participants had no abnormality and with no history of cerebrovascular diseases according to medical history collection and physical examination. All study subjects were originally from the northern part of Henan province and lived there for\>3 years. They were not married with other ethnicities for more than two consecutive generations. Their educational levels were above junior middle school. Exclusion criteria: those aged \> 45 years or \< 18 years; those with other types of cerebral diseases; severe systemic diseases; the time interval between onset of stroke and sampling collection \> 1 week; refusal to participate in this study; inability to effectively cooperate with researches due to other reasons. In this single-center study, case-control study method was adopted to statistically compare the genetic types between two groups. Prior to this study, all subjects signed informed consents. The study procedures were approved by the Ethics Committee of Xinxiang Medical College.

2.2. Data collection {#s0020}
--------------------

Baseline data of all participants were recorded and an electronic medical record was established. The registration data mainly included demographic data, current disease, medical history, family history, medication history, the results of physical examination, routine blood test and biochemical examinations, and imaging examination of the head and neck.

2.3. Detection of gene {#s0025}
----------------------

A portion of 2 ml of venous blood was collected from the subjects and the cells were isolated by centrifuge at 4000 rpm. Sample DNA was extracted using the QIAGEN DNA extraction kit. After the sample DNA concentration was measured with a spectrophotometer, the PDE4D gene locus was subject to high-throughput sequencing using the llumina Miseq high-throughput sequencing platform. The specific experimental conditions were performed strictly according to the manufacturer\'s instructions. GeneMapper 4.0 was used for sample genotype data analysis and raw data processing.

2.4. Statistical analysis {#s0030}
-------------------------

The statistical analyses were performed by SPSS version 19.0 software. Statistical significance was defined as two-sided P \< 0.05. Mean ± standard deviation or standard error were presented of the continuous variables. Counting data were represented by frequency or constituent ratio. Univariate and multivariate logistic regression analyses were used to present the odds ratio (OR). The chi-square test was performed to calculate the qualitative data comparison and the Hardy-Weinberg equilibrium test (HWE).

3. Results {#s0035}
==========

3.1. Clinical characteristics {#s0040}
-----------------------------

In the case group, there were 193 patients including 147 male and 46 female, aged 33.2 years on average. In the control group, 200 subjects were recruited with a male to female ratio of 2.64:1 and an average age of 31.1 years. There was no significant difference regarding all parameters between two groups (all *P* \> 0.05), as illustrated in [Table 1](#t0005){ref-type="table"}.Table 1Baseline data.Control group (2 0 0)Case group (1 9 3)*P*Age31.1 ± 17.933.2 ± 12.8\<0.001Gender ratio2.64:1 (145:55)3.2:1 (147:46)\<0.05Smoking history48% (96)61.1% (1 1 8)\<0.05Drinking history52.5% (1 0 5)54.9% (1 0 6)\<0.001Diabetes history9.5% (19)14% (27)\<0.001Hypertension history16% (32)38.9% (75)\<0.05CVD family history7.5% (15).20.7% (40)\<0.05

3.2. HWE test {#s0045}
-------------

In the case and control groups, the minimum allele frequency of SNP83 was 0.40 and 0.48, and the minimum allele frequency of SNP87 was 0.37 and 0.40. Chi-square test was consistent with HWE test, indicating that the distribution of data in this study can represent the gene distribution of the population.

3.3. Comparison of SNP83 polymorphism and allele frequency between the case and control groups {#s0050}
----------------------------------------------------------------------------------------------

Comparison of SNP83 polymorphism of PDE4D gene between the case and control groups demonstrated that the distribution frequency of CC homozygote was 34.2% in the case group, significantly higher compared with 18% in the control group (*P* \< 0.005). The frequency of C allele in the case group was 59.3%, significantly higher than 48.3% in the control group (*P* \< 0.001, OR: 1.564, 95% CI 1.180--2.075), as illustrated in [Table 2](#t0010){ref-type="table"}, [Table 3](#t0015){ref-type="table"}.Table 2SNP83 Genotype distribution frequency.GenotypeControl groupCase groupχ^２^PCC36 (18%)66 (34.2%)10.0020.001CT97 (50.3%)121 (60.5%)TT43 (21.5%)30 (15.5%)Table 3SNP83 Allele frequency.GenotypeControl groupCase groupχ^２^POR95%CIC193 (48.3%)229 (59.3%)9.6930.0021.5641.180--2.075T207 (51.7%)157 (40.7%)

3.4. Comparison of SNP87 polymorphism and allele frequency between the case and control groups {#s0055}
----------------------------------------------------------------------------------------------

After the SNP87 polymorphism of PDE4D gene was compared between two groups, the distribution frequency of CC homozygote was 49.2% in the case group, higher than 42.0% in the control group. No statistical significance was observed in terms of the distribution frequency of CC, CT and TT genotypes between two groups (all *P* \> 0.05). There was no significant difference in the distribution frequency of C and T alleles at the SNP87 polymorphism between two groups (both *P* \> 0.05), as demonstrated in [Table 4](#t0020){ref-type="table"}, [Table 5](#t0025){ref-type="table"}.Table 4SNP87 Genotype distribution frequency.GenotypeControl groupCase groupχ^２^PCC84 (42%)95 (49.2%)2.9130.233CT70 (35%)53 (27.5%)TT46 (23%)45 (23.3%)Table 5SNP87 Allele frequency.GenotypeControl groupCase groupχ^２^POR95% CIC238 (59.5%)243 (63%)0.5350.4641.1140.834--1.487T156 (40.5%)143 (37%)

4. Discussion {#s0060}
=============

PDE4D is distributed in vascular smooth muscle cells, endothelial cells and various types of inflammatory cells. It selectively degrades the second messenger cAMP and prevents the proliferation and migration of vascular smooth muscle induced by cAMP, ultimately affecting the occurrence and progression of stroke by inhibiting arteriosclerosis ([@b0055]). In recent years, multiple studies focusing on the association between stroke and PDE4D gene polymorphisms have been conducted, whereas the results are inconsistent among these investigations. Several studies have proposed that stroke is correlated with the SNP83 and SNP87 polymorphisms of PDE4D gene, whereas others have identified no significant association between SNP87 gene polymorphism and the risk of stroke ([@b0050], [@b0100], [@b0065], [@b0040]). This phenomenon prompts that the correlation between genetic polymorphism and stroke is related to multiple factors, such as ethnicity, region and age, etc. The pathogenesis of ischemic stroke is complex and collectively affected by environmental and genetic factors. For young and middle-aged adults, the pathogenesis of ischemic stroke is more likely to be affected by genetic factors. At present, the studies analyzing the risk of stroke and genetic factors in young adults are still lacking. Gene sequencing technology is an approach to unravel the genetic code of humans. Since 1975 when British biochemist Frederick Sanger applied the first-generation gene sequencing of chain termination method to determine the genomic sequence of a type of phage, novel gene sequencing technologies have been increasingly discovered.

High-throughput sequencing enables simultaneous sequencing of hundreds of thousands to millions of DNAs, which significantly shortens the time and reduces the cost of gene sequencing ([@b0105]). It allows for scanning and detection of mutation sites at the entire genome level, delivers accurate detection of gene polymorphism. High-throughput sequencing has been widely applied to identify the candidate genes of multiple diseases ([@b0110]).

At present, most studies related to gene polymorphism are performed using the polymerase chain reaction-restriction fragment length polymorphism method (PCR-RFLP). The DNA fragments to be detected are digested with restriction enzymes, and then the digested products are subject to electrophoresis. The diversity of gene sequences from different sources is compared by the diversity of the fragments. The limitations of this method are complicated procedures, time-consuming operation, relatively long cycle of experiment and limited sensitivity, which are not conducive to the identification of unknown gene mutations. In this study, high-throughput sequencing technology was first applied into gene detection and reported the association between the onset of ischemic stroke and with SNP83 and SNP87 polymorphisms of PDE4D gene in young stroke patients from the northern Henan province, China. By genotyping the SNP83 and SNP87 polymorphisms in 193 patients with ischemic stroke aged 18--45 years and 200 healthy controls, the genotype and allele frequencies of SNP83 and SNP87 polymorphisms were detected and statistically compared. The results demonstrated that the risk of stroke in young individuals carrying the SNP83C allele was higher than that in those carrying the T allele, whereas there was no significant association between the frequency of SNP87 gene and the incidence of stroke in young patients. These findings are consistent with previous investigations. Nevertheless, other studies have yielded different results. For example, a study conducted in 2014 reported that there was no association between SNP83 polymorphism of PDE4D gene, stroke patients and patients with 5 subtypes of stroke. Both two studies in 2009 and 2012 demonstrated that the SNP87C allele was a risk factor of stroke ([@b0070], [@b0020]). The potential causes of the diverse findings are as follows: 1. The sample size is insufficient and small; 2. The frequency distribution of PDE4D genotypes and alleles varies among individuals from different countries, regions, races, ethnicities and age; 3. Inclusion criteria for ischemic stroke are different.

Taken together, the results of this study demonstrate that the SNP83 polymorphism of PDE4D gene is associated with the incidence of stroke in young population from the northern Henan province. However, The SNP87 polymorphism of PDE4D gene is not significantly associated with the onset of stroke in young stroke patients from the northern Henan province. Maybe the number of study subjects was relatively small, and multicenter studies with larger sample sizes are needed to confirm our findings.

5. Conclusion {#s0065}
=============

In conclusion, the SNP83 polymorphism of PDE4D gene was significantly associated with the risk of IS from the northern Henan province. This result may contribute to the young adult who carry the C allele to prevent the risk of IS in the future. And next, we will focus on how to reduce the incidence of the high-risk groups. Start with prevention in advance, depressing the incidence of IS.
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